Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The pharmacological treatment of mood disorders remains focused around the use of monoamine potentiating agents for the management of depression. There are, however, a growing number of agents available for management of bipolar disorder, with both anticonvulsants and atypical antipsychotic drugs showing promise in the management of bipolar depression. © 2006 Elsevier Ltd. All rights reserved.

Original publication

DOI

10.1383/psyt.2006.5.5.162

Type

Journal article

Journal

Psychiatry

Publication Date

01/05/2006

Volume

5

Pages

162 - 166